Novel Cyclic Peptides for Targeting EGFR and EGRvIII Mutation for Drug Delivery

The epidermal growth factor-epidermal growth factor receptor (EGF-EGFR) pathway has become the main focus of selective chemotherapeutic intervention. As a result, two classes of EGFR inhibitors have been clinically approved, namely monoclonal antibodies and small molecule kinase inhibitors. Despite...

Full description

Saved in:
Bibliographic Details
Main Authors: Olga Furman (Author), Alisa Zaporozhets (Author), Dror Tobi (Author), Andrii Bazylevich (Author), Michael A. Firer (Author), Leonid Patsenker (Author), Gary Gellerman (Author), Bat Chen R. Lubin (Author)
Format: Book
Published: MDPI AG, 2022-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available